Resources
53 Results (showing 1 - 10)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 10/7/2019 (updated 3/25/2024)
Highlighting effective internal controls, which are the basis for strong financial systems and processes that prevent fraud, waste and abuse.
Posted 10/7/2019 (updated 3/25/2024)
Adopting a Shared Framework for Community Collaboration Webinar and Resources
Posted 11/19/2019 (updated 3/25/2024)
The intersection of opioid abuse, particularly injection drug use (IDU), and HIV is well documented; in fact, IDU is the second most frequent route of HIV transmission. Injection drug use, either directly or via sexual contact with an IDU partner, accounts for one-third of the estimated AIDS cases since the beginning of the epidemic, and 18 percent of new infections in the United States.
Posted 1/25/2022 (updated 3/26/2024)
RCORP-TA is pleased to provide technical assistance resources related to grantee business operations that we have prepared for grantees. RCORP-TA is providing these resources to assist grantees on aspects of their business operations that are continuously impacted and routinely challenged by factors associated with living and working in rural communities. Please see the below linked guidance documents and descriptions as they may be of interest to you.
Posted 2/21/2022 (updated 3/26/2024)
The opioid epidemic is a result of a complex system of varied and interrelated factors. This webinar will introduce a systems thinking approach and tools to address complex public health challenges. The webinar will provide an overview of systems tools and describe opportunities to develop systems further thinking capacity for application to grantees’ local opioid response.
Posted 3/22/2022 (updated 3/27/2024)
The purpose of this document is to provide detailed guidelines of the Nurse Care Manager Model of Office Based Addiction Treatment program for management of substance use disorders, with particular emphasis on treatment of opioid use disorder with buprenorphine (alone and in combination with naloxone) and naltrexone (oral and extended-release injectable formulations).
Posted 9/25/2023 (updated 3/27/2024)
The Substance Abuse and Mental Health Services Administration (SAMHSA) now has the "Engaging Community Coalitions to Decrease Opioid Overdose Deaths Practice Guide" available, as a product of the HEALing Communities Study (HCS).
Posted 3/21/2023 (updated 3/27/2024)
Researchers at Indiana University conducted one-on-one interviews with clinical providers and other stakeholders in the recovery arena to better understand the slow uptake of the drug most used to treat opioid use disorder. Biases against buprenorphine was the most consistent theme, though the reason for bias differed amongst stakeholders. Clinical providers and behavioral health care providers preferred the abstinence approach rather than use of medications.
Posted 10/24/2022 (updated 3/27/2024)
In this session, we will give an overview of the program, discuss expectations, grant deliverables, and highlight trends in psychostimulant use. We will also discuss the role of the HRSA Project Officer, Grants Management Specialist, Technical Expert Leads, and Evaluation Team.
Posted 6/3/2022 (updated 3/27/2024)
The opioid settlement is a significant opportunity to improve substance use disorder prevention, treatment, and recovery. By attending to the evidence base and leveraging other funding sources, we can transform our behavioral health system to work better for people with substance use disorder. The Steadman Group related their experience in facilitating opioid settlement governance so you can optimize your settlement spending!